Literature DB >> 15107614

Murine FGF-inducible kinase is rapidly degraded via the nuclear ubiquitin-proteosome system when overexpressed in NIH 3T3 cells.

Gregory F Alberts1, Jeffrey A Winkles.   

Abstract

FGF-inducible kinase (Fnk) is a member of the polo-like kinase family of structurally-related serine/threonine protein kinases. These kinases appear to play critical roles in normal cell cycle progression and in the DNA damage response. In the case of Fnk, several reports indicate that this protein normally functions in cells as a stress-activated checkpoint kinase. However, when Fnk is ectopically overexpressed in cells, it likely becomes constitutively activated, and this promotes cell cycle arrest and apoptosis. In the present paper, we report that murine Fnk has a short half-life when transiently overexpressed in transfected NIH 3T3 fibroblasts. In contrast, when a kinase-deficient Fnk mutant protein, Fnk-K92M, is overexpressed in transfected cells, it is significantly more stable. We also found that Fnk-wild-type (WT) and Fnk-K92M are present in both the nucleus and cytoplasm of transfected cells and that Fnk nuclear export requires CRM1 function. Both of these proteins are degraded in cells via the nuclear ubiquitin-proteosome system; however, Fnk-K92M does not enter the nuclear compartment as efficiently as Fnk-WT and consequently it is significantly more stable. These results demonstrate that Fnk expression levels in transfected cells can be regulated by nuclear-cytoplasmic trafficking, ubiquitination, and proteosome-dependent degradation. Furthermore, our studies indicate that the downregulation of endogenous Fnk activity in stressed cells may occur, at least in part, by Fnk nuclear translocation and proteosomal degradation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107614

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  6 in total

1.  Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression.

Authors:  Guillermo de Cárcer; Beatriz Escobar; Alonso M Higuero; Laura García; Alejandra Ansón; Gema Pérez; Manuela Mollejo; Gerard Manning; Bárbara Meléndez; José Abad-Rodríguez; Marcos Malumbres
Journal:  Mol Cell Biol       Date:  2011-01-18       Impact factor: 4.272

2.  Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel.

Authors:  Cen Li; Soyoung Park; Xiaowen Zhang; Wei Dai; Dazhong Xu
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

Review 3.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

4.  Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin.

Authors:  Thierry J Horner; Wi S Lai; Deborah J Stumpo; Perry J Blackshear
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

5.  Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions.

Authors:  Yali Yang; Jingxiang Bai; Rulong Shen; Sharron A N Brown; Elena Komissarova; Ying Huang; Ning Jiang; Gregory F Alberts; Max Costa; Luo Lu; Jeffrey A Winkles; Wei Dai
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

6.  Phosphorylation of PLK3 Is Controlled by Protein Phosphatase 6.

Authors:  Cecilia Aquino Perez; Matous Palek; Lenka Stolarova; Patrick von Morgen; Libor Macurek
Journal:  Cells       Date:  2020-06-20       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.